These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 7388822)

  • 1. Protection by testosterone from fluorouracil-induced toxicity without loss of anticancer acitvity against autochthonous murine breast tumors.
    Stolfi RL; Sawyer RC; Nayak R; Spiegelman S; Martin DS
    Cancer Res; 1980 Aug; 40(8 Pt 1):2730-5. PubMed ID: 7388822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of 5-fluorouracil host-toxicity and chemotherapeutic efficacy against human colon tumors by 5-(Phenylthio)acyclouridine, a uridine phosphorylase inhibitor.
    Al Safarjalani ON; Rais R; Shi J; Schinazi RF; Naguib FN; el Kouni MH
    Cancer Chemother Pharmacol; 2006 Nov; 58(5):692-8. PubMed ID: 16528530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of L-histidinol on the metabolism of 5-fluorouracil in the BALB/c x DBA/8 F1 murine tumor system.
    Sawyer RC; Stolfi RL; Martin DS
    Cancer Res; 1988 Dec; 48(23):6664-8. PubMed ID: 2460227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased host toxicity in vivo during chronic treatment with 5-flourouracil.
    Darnowski JW; Sawyer RC; Stolfi RL; Martin DS; Lau-Cam CA
    Cancer Chemother Pharmacol; 1985; 14(1):63-9. PubMed ID: 3965161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Failure of L-histidinol to improve the therapeutic efficiency of 5-fluorouracil against murine breast tumors.
    Stolfi RL; Sawyer RC; Martin DS
    Cancer Res; 1987 Jan; 47(1):16-20. PubMed ID: 3791203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potentiation of 5-fluorouracil efficacy by the dihydrouracil dehydrogenase inhibitor, 5-benzyloxybenzyluracil.
    Naguib FN; Hao SN; el Kouni MH
    Cancer Res; 1994 Oct; 54(19):5166-70. PubMed ID: 7923135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antitumor activity of ZD1694 (tomudex) against human head and neck cancer in nude mouse models: role of dosing schedule and plasma thymidine.
    Cao S; McGuire JJ; Rustum YM
    Clin Cancer Res; 1999 Jul; 5(7):1925-34. PubMed ID: 10430100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapy of 7,12-dimethylbenz(a)anthracene-induced rat mammary carcinomas with combinations of 5-fluorouracil and 2 alpha-methyldihydrotestosterone propionate.
    Teller MN; Stock CC; Bowie M; Chou TC; Budinger JM
    Cancer Res; 1982 Nov; 42(11):4408-12. PubMed ID: 6812946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-dose 5-fluorouracil with delayed uridine "rescue" in mice.
    Martin DS; Stolfi RL; Sawyer RC; Spiegelman S; Young CW
    Cancer Res; 1982 Oct; 42(10):3964-70. PubMed ID: 7104997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of 5-fluorouracil-induced toxicity in mice with interferon or with the interferon inducer, polyinosinic-polycytidylic acid.
    Stolfi RL; Martin DS; Sawyer RC; Spiegelman S
    Cancer Res; 1983 Feb; 43(2):561-6. PubMed ID: 6184150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of chemotherapeutic drug activity with polyribonucleotides or with interferon.
    Stolfi RL; Martin DS
    J Biol Response Mod; 1985 Dec; 4(6):634-9. PubMed ID: 2418161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of uridine rescue to enhance the antitumor selectivity of 5-fluorouracil.
    Klubes P; Cerna I
    Cancer Res; 1983 Jul; 43(7):3182-6. PubMed ID: 6850628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of adjuvant chemotherapeutic activity against primary and metastatic spontaneous murine tumors.
    Fugmann RA; Anderson JC; Stolfi RL; Martin DS
    Cancer Res; 1977 Feb; 37(2):496-500. PubMed ID: 832274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fifty-five percent complete remission of mammary carcinoma in mice with 5-fluorouracil and chloroquine.
    Shoemaker JP
    Cancer Res; 1978 Sep; 38(9):2700-2. PubMed ID: 679173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of medroxyprogesterone acetate on antitumor efficacies and side effect of 5-fluorouracil].
    Ashizawa T; Ishida H; Okabe M; Gomi K
    Gan To Kagaku Ryoho; 1993 May; 20(7):941-7. PubMed ID: 8489300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic activity of maleic anhydride-vinyl ether copolymers against spontaneous, autochthonous murine mammary tumors.
    Stolfi RL; Martin DS
    Cancer Treat Rep; 1978 Nov; 62(11):1791-6. PubMed ID: 728897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toxicity and antineoplastic effect of (24R)-1,24-dihydroxyvitamin D3 (PRI-2191).
    Wietrzyk J; Pełczyńska M; Madej J; Dzimira S; Kuśnierczyk H; Kutner A; Szelejewski W; Opolski A
    Steroids; 2004 Sep; 69(10):629-35. PubMed ID: 15465107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antitumor activity of menogaril alone, and in combination against human mammary cancer models in mice and rats.
    Yoshida M; Fujioka A; Nakano K; Kobunai T; Saito H; Toko T; Takeda S; Unemi N
    Anticancer Res; 1996; 16(3A):1155-9. PubMed ID: 8702227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo antitumor activity of 5-fluorocytosine on human colorectal carcinoma cells genetically modified to express cytosine deaminase.
    Huber BE; Austin EA; Good SS; Knick VC; Tibbels S; Richards CA
    Cancer Res; 1993 Oct; 53(19):4619-26. PubMed ID: 8402637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-dose metronomic combined with intermittent bolus-dose cyclophosphamide is an effective long-term chemotherapy treatment strategy.
    Shaked Y; Emmenegger U; Francia G; Chen L; Lee CR; Man S; Paraghamian A; Ben-David Y; Kerbel RS
    Cancer Res; 2005 Aug; 65(16):7045-51. PubMed ID: 16103050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.